In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


R2D2 in the OR

Executive Summary

For years, robotic surgery was regarded skeptically as space-aged medicine. But a new generation of minimally-invasive procedures involving the reconstruction of delicate and critical body structures is giving life to this technology. Now the domain of small companies, signs of interest by large device companies could give this industry a major boost.

You may also be interested in...

The Markets for Image-Guided Surgery: Location, Location...and Guidance

The market for image-guided surgical systems is worth $1.2 billion in 2005, according to a report recently issued by Medtech Insight, $1 billion attributable to interventional imaging, and $155.2 million to the sales of surgical navigation systems. The market is expected to experience a compound annual growth rate of 5.5% for the next several years, a slightly higher rate than the 4.1% forecast for the imaging industry as a whole.

CAOS Causes Robotic Revival in Orthopedics

It has been nearly a decade since the promise of medical robotics, first unveiled in orthopedic surgery, was introduced with the launch of the Robodoc surgical system. But robotics and other computer-assisted tools such as navigation systems failed to live up to their early hype, and surgeons were slow to adopt the new technology. However, according to presentations made at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting, held in February in Dallas, improved technology appears to be generating increased interest among orthopedic surgeons in robotics, navigation systems, and other computer-assisted tools, resulting in the emergence of a new sub-specialty called computer-assisted orthopedic surgery (CAOS).

EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments

While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts